NM_198437.3:c.91T>A

Variant summary

Our verdict is Uncertain significance.
+4 Uncertain · Hot
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 4 classification points (ACGS-UK Somatic Oncogenicity v2025). O1_StrongO4_SupportingB3_Supporting

The NM_198437.3(AURKA):c.91T>A (p.Phe31Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene AURKA is a tumor suppressor gene (CancerMine: 4 TSG, 51 oncogene, 8 driver citations). The gene AURKA is a known oncogene (CancerMine: 4 TSG, 51 oncogene, 8 driver citations). The gene AURKA is a cancer driver gene (CancerMine: 4 TSG, 51 oncogene, 8 driver citations). The variant allele was found at a cumulative frequency of 0.235 (AC=379,568) in the gnomAD database across 1,613,914 control chromosomes, including 50,544 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.659. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). This exact variant is established as oncogenic in: CGI (Cancer Genome Interpreter). The variant has been observed in cBioPortal in 13 samples across 5 studies and 9 cancer types; somatic enrichment level: SUPPORTING (Observed repeatedly in cBioPortal somatic datasets.). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.22 ( 4562 hom., cov: 33)
Exomes 𝑓: 0.24 ( 45982 hom. )

Consequence

AURKA
NM_198437.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: -0.555

Publications

114 publications found
Variant links:
Genes affected
AURKA (HGNC:11393): (aurora kinase A) The protein encoded by this gene is a cell cycle-regulated kinase that appears to be involved in microtubule formation and/or stabilization at the spindle pole during chromosome segregation. The encoded protein is found at the centrosome in interphase cells and at the spindle poles in mitosis. This gene may play a role in tumor development and progression. A processed pseudogene of this gene has been found on chromosome 1, and an unprocessed pseudogene has been found on chromosome 10. Multiple transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
AURKA Gene-Disease associations (from GenCC):
  • breast cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_198437.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 4 points.

O1Established oncogenic variant
CGI exact DNA-change oncogenic — Strong (O1); O1 contributing sources (4.0 pts): CGI (Cancer Genome Interpreter)
O4Enriched in somatic variant database
Enriched in cBioPortal (pre-computed score ≥ 1.0) — Supporting (O4); cBioPortal: samples=13 | studies=5 | cancer types=9 | level=SUPPORTING | points=1.0 | reason: Observed repeatedly in cBioPortal somatic datasets.
B3Computational evidence does not support deleterious effect
Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_198437.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

AURKA NM_198437.3
MANE Select
HGVSc / HGVSpc.91T>Ap.Phe31Ile
Exon rankExon 3 of 9
missense
Prot: NP_940839.1UniProt: O14965
AURKA NM_001424418.1
HGVSc / HGVSpc.193T>Ap.Phe65Ile
Exon rankExon 5 of 11
missense
Prot: NP_001411347.1
AURKA NM_001424419.1
HGVSc / HGVSpc.193T>Ap.Phe65Ile
Exon rankExon 5 of 11
missense
Prot: NP_001411348.1

Ensembl Transcripts

AURKA ENST00000395915.8
TSL:1MANE Select
HGVSc / HGVSpc.91T>Ap.Phe31Ile
Exon rankExon 3 of 9
missense
Prot: ENSP00000379251.3UniProt: O14965
AURKA ENST00000312783.10
TSL:1
HGVSc / HGVSpc.91T>Ap.Phe31Ile
Exon rankExon 4 of 10
missense
Prot: ENSP00000321591.6UniProt: O14965
AURKA ENST00000347343.6
TSL:1
HGVSc / HGVSpc.91T>Ap.Phe31Ile
Exon rankExon 3 of 9
missense
Prot: ENSP00000216911.2UniProt: O14965

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.223
AC:33952
Hom:4556
AN:152018
Cov:33
GnomAD2 exomes
AF: 0.278
AC:69789
AN:251444
GnomAD4 exome
AF: 0.236
AC:345594
Hom:45982
AN:1461776
Cov:41
GnomAD4 genome
AF: 0.223
AC:33974
Hom:4562
AN:152138
Cov:33
TOPMed (Bravo)
AF: 0.222
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.173
AC:8732
Hom:988
AN:50362
Local & regional cohorts 11 sources
ABraOM SABE-WGS-1171
AF: 0.213
AC:498
Hom:49
AN:2342
ChinaMAP Phase 1
AF: 0.671
Denmark Genome
AF: 0.257
AC:77
AN:300
ESP6500 (Exome Variant Server)
AF: 0.188
AC:2448
AN:13006
GenomeAsia100K
AF: 0.453
AC:1576
AN:3478
Korea4K (4,157 Koreans)
AF: 0.666
AC:4817
AN:7234
Qatari Genome
AF: 0.235
AC:472
AN:2010
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.655
AC:80397
Hom:26369
AN:122832
Turkish Variome
AF: 0.239
AC:1606
Hom:222
AN:6718
UK10K
AF: 0.223
AC:1689
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.690
AC:6181
Hom:2136
AN:8960
Showing 17 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.231 *22229620 0.233 *242610428
BipEx
(Bipolar disorder (including schizoaffective))
0.220 625128420 0.218 628128844
Epi25
(Epilepsy)
0.254 1064341958 0.234 1562666884
SCHEMA
(Schizophrenia)
0.337 52312155412 0.313 76764245496
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
AURKA-related disorder (1)
-
-
-
Colon cancer, susceptibility to (1)

Computational Scores

AlphaGenome AVI
Uncertain12
AlphaMissense
Benign0.058
BayesDel_addAF
Benign-0.58T
BayesDel_noAF
Benign-0.46
CADD
Benign0.59
DANN
Benign0.76
DEOGEN2
Benign0.0098T
Eigen
Benign-1.6
Eigen_PC
Benign-1.7
FATHMM_MKL
Benign0.067N
FuncVEP CTI
Benign0.0011
GPN-Star LLR
N/A-3.7
GPN-Star score
N/A3.7
LIST_S2
Benign0.43T
MetaRNN
Benign0.0000035T
MetaSVM
Benign-0.99T
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign-0.56
popEVE
Benign-3.4
PrimateAI
Benign0.41T
PROVEAN
Benign-0.10N
REVEL
Benign0.052
Sift
Benign0.50T
Sift4G
Benign0.40T
VESM-3B
Benign-2.0
Showing 25 of 25 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.